ADMA Biologics Inc (NASDAQ:ADMA)

9.35
Delayed Data
As of Mar 03
 -0.15 / -1.58%
Today’s Change
6.76
Today|||52-Week Range
14.00
-16.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

--
AssetsCash----26.1M--
 
 
Short Term Investment Cash-141.2K12.4M13.6M--
 
 
 
 
Cash & Short Term Investments87.8K12.5M29.1M--
 
 
 
 
 
ReceivablesReceivables0.0039.1K0.00--
 
 
 
InventoriesInventories1.1M1.3M1.7M--
 
 
 
 
 
Current AssetsPrepaid Expenses59.2K107.8K298.7K--
 
 
 
 
Current Assets1.3M13.9M31.1M--
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross1.5M1.6M1.8M--
 
 
 
 
Depreciation-686.2K-825.4K-1.0M--
 
 
 
 
Other Assets433.7K376.0K162.2K--
 
 
 
 
Total Assets2.9M15.6M32.0M--
 
 
 
 
 
LiabilitiesAccounts Payable1.3M1.1M2.7M--
 
 
 
 
Short Term Debt460.6K11.6K12.7K--
 
 
 
 
Accrued Expenses537.7K747.1K860.1K--
 
 
 
 
Other Current Liabilities537.7K747.1K935.7K--
 
 
 
 
Other Liabilities2.3M1.8M3.7M--
 
 
 
 
 
Total LiabilitiesLong Term Debt88.6K4.0M5.1M--
 
 
 
 
Other Liabilities0.00229.3K0.00--
 
 
Total Liabilities2.5M6.1M10.4M--
 
 
 
 
 
EquityMinority Interest0.000.000.00----
Preferred Stock8.2K0.000.00--
 
 
Common Equity377.6K9.4M21.6M--
 
 
 
 
Total Shareholder Equity385.8K9.4M21.6M--
 
 
 
 
 
Share InformationCommon Shares Outstanding408.6K4.6M9.3M--
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account